(S)-6-Fluoro-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various bioactive compounds. Its structural features make it valuable in the development of drugs targeting neurological disorders, particularly those related to serotonin and dopamine pathways. The compound is often employed in research to design and optimize molecules for improved efficacy and selectivity in treating conditions like depression, anxiety, and Parkinson's disease. Additionally, its chiral nature allows for the creation of enantiomerically pure drugs, enhancing therapeutic outcomes and reducing side effects. Researchers also explore its potential in developing novel therapeutics for other central nervous system disorders.